Trial
NCT05238831
SMMART Adaptive Clinical Treatment (ACT) Trial
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
OHSU Knight Cancer Institute
Collaborators
Genentech, Inc.; Oregon Health and Science University
Condition
Advanced Breast Carcinoma
Intervention
Alectinib
Why stopped
Withdrawn due to a change in therapeutic interventions.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-23